Elutia ELUT
NASDAQ ELUT
$0.95 +0.03 (+3.73%)
As of: Aug 21, 2026 · 3:59 PM EDT

Elutia (ELUT) Other Non-Current Liabilities (2019 - 2026)

Elutia (ELUT) posted Other Non-Current Liabilities of $3.4 million for Q1 2026, up 8.48% sequentially from $3.1 million in Q4 2025, and down 28.43% YoY from $4.7 million in Q1 2025.

Elutia (ELUT) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends

Elutia has reported Other Non-Current Liabilities for 8 years, with the latest figure at $3.4 million in Q1 2026.

  • Quarterly Other Non-Current Liabilities fell 28.43% year-over-year to $3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (down 28.43% YoY) and the FY2025 annual result came in at $3.1 million, down 80.57% from the prior year.
  • Other Non-Current Liabilities advanced to $3.4 million in Q1 2026 per ELUT's latest filing, from $3.1 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $16.5 million in Q1 2022 and troughed at $86000.0 in Q3 2022.
  • A 5-year average of $5.1 million and a median of $3.4 million in 2026 frame the typical range for Other Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities plunged 99.48% in 2022, then surged 9947.24% in 2023.
  • Over 5 years, Other Non-Current Liabilities stood at $127000.0 in 2022, then soared by 9947.24% to $12.8 million in 2023, then climbed by 25.99% to $16.1 million in 2024, then slumped by 80.57% to $3.1 million in 2025, then climbed by 8.48% to $3.4 million in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $3.4 million, $3.1 million, and $4.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn
10 Elutia 40.75 Mn 20.85 Mn 1.45 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.39 Mn
Dec 31, 2025 3.12 Mn
Sep 30, 2025 4.03 Mn
Jun 30, 2025 8.97 Mn
Mar 31, 2025 4.74 Mn
Dec 31, 2024 16.08 Mn
Sep 30, 2024 6.24 Mn
Jun 30, 2024 1.57 Mn
Mar 31, 2024 7.66 Mn
Dec 31, 2023 12.76 Mn
Sep 30, 2023 433,000.00
Jun 30, 2023 351,000.00
Mar 31, 2023 207,000.00
Dec 31, 2022 127,000.00
Sep 30, 2022 86,000.00
Jun 30, 2022 899,000.00
Mar 31, 2022 16.52 Mn
Dec 31, 2021 698,000.00
Sep 30, 2021 16.55 Mn
Jun 30, 2021 16.59 Mn